Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam Blattner-Johnson

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Seminars in Cancer Biology|June 11, 2021
Precision medicine in pediatric solid cancersMirjam Blattner-Johnson, David T W Jones, Elke Pfaff
Klinische Padiatrie|March 27, 2021
Heterozygous PALB2 Mutation in a Boy with Acute Lymphoblastic Leukemia and Subsequent Metastatic Ewing SarcomaCarla Mehaffey, Dagmar Wahl, Tina Schaller, et al.
JCO Precision Oncology|January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug TargetsElke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
Nature Cancer|January 26, 2023
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancersVenu Thatikonda, S M Ashiqul Islam, Robert J Autry, et al.
Cancer Research|December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid TumorsDina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Seminars in Cancer Biology|June 11, 2021
Precision medicine in pediatric solid cancersMirjam Blattner-Johnson, David T W Jones, Elke Pfaff
Klinische Padiatrie|March 27, 2021
Heterozygous PALB2 Mutation in a Boy with Acute Lymphoblastic Leukemia and Subsequent Metastatic Ewing SarcomaCarla Mehaffey, Dagmar Wahl, Tina Schaller, et al.
JCO Precision Oncology|January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug TargetsElke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
Nature Cancer|January 26, 2023
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancersVenu Thatikonda, S M Ashiqul Islam, Robert J Autry, et al.
Cancer Research|December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid TumorsDina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Pageof 4